Literature DB >> 15489488

Ophthalmological manifestations in segmental neurofibromatosis type 1.

M Ruggieri1, P Pavone, A Polizzi, M Di Pietro, A Scuderi, A Gabriele, A Spalice, P Iannetti.   

Abstract

AIMS: To study the ophthalmological manifestations in individuals with the typical features of neurofibromatosis type 1 (NF1) circumscribed to one or more body segments, usually referred to as segmental NF1.
METHODS: Visual acuity and colour tests, visual field examination, slit lamp biomicroscopy of the anterior segment, and a detailed examination of the retina by indirect ophthalmoscopy were performed at diagnosis and follow up in 72 consecutive subjects (29 males, 43 females; aged 1-64 years; mean age 14.6 years) seen at the university departments of paediatrics in Catania and Rome, Italy, during years 1990-2003, who had in restricted body areas: (1) typical pigmentary manifestations of NF1 (cafe au lait spots and freckling) only (n = 48); (2) NF1 pigmentary manifestations and neurofibromas alone (n = 2); (3) neurofibromas only (n = 15); and (4) plexiform neurofibromas only (n = 7).
RESULTS: None of the 72 patients had Lisch nodules in the iris irrespective of age at eye examination or hypertelorism (a "minor" NF1 feature) and none developed typical associated ophthalmological NF1 complications. An additional child had an isolated optic pathways glioma (OPG), which behaved both biologically and radiographically as an NF1 associated OPG.
CONCLUSIONS: This represents the first systematic study reporting on eye involvement in the largest series of individuals at different ages having segmental NF1. As one of the postulated mechanisms to explain segmental NF1 is somatic mosaicism for the NF1 gene (so far demonstrated only in two patients) the present findings could be explained either by the fact that the eye is too far from the mutated area with NF1 lesions in most cases or by the NF1 (or other "predisposing" or "cooperating") gene mutation restricted to too few cellular clones or to tissues embryologically different from the eye.

Entities:  

Mesh:

Year:  2004        PMID: 15489488      PMCID: PMC1772378          DOI: 10.1136/bjo.2004.043802

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  31 in total

Review 1.  Extracutaneous analogies of Blaschko lines.

Authors:  H D Rott
Journal:  Am J Med Genet       Date:  1999-08-06

Review 2.  Segmental forms of autosomal dominant skin disorders: the puzzle of mosaicism.

Authors:  P H Itin; S A Buechner
Journal:  Am J Med Genet       Date:  1999-08-06

3.  A clinical study of patients with multiple isolated neurofibromas.

Authors:  P Blakley; D N Louis; M P Short; M MacCollin
Journal:  J Med Genet       Date:  2001-07       Impact factor: 6.318

4.  Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.

Authors:  J Antinheimo; R Sankila; O Carpén; E Pukkala; M Sainio; J Jääskeläinen
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

5.  Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene.

Authors:  S Tinschert; I Naumann; E Stegmann; A Buske; D Kaufmann; G Thiel; D E Jenne
Journal:  Eur J Hum Genet       Date:  2000-06       Impact factor: 4.246

Review 6.  The clinical and diagnostic implications of mosaicism in the neurofibromatoses.

Authors:  M Ruggieri; S M Huson
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

7.  Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2): no longer neurofibromatosis type 5 (NF5).

Authors:  M Ruggieri
Journal:  Am J Med Genet       Date:  2001-06-15

8.  Segmental neurofibromatosis in childhood.

Authors:  Robert Listernick; Anthony J Mancini; Joel Charrow
Journal:  Am J Med Genet A       Date:  2003-08-30       Impact factor: 2.802

9.  Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis?

Authors:  M Leverkus; L Kluwe; E-M Röll; G Becker; E-B Bröcker; V F Mautner; H Hamm
Journal:  Br J Dermatol       Date:  2003-04       Impact factor: 9.302

10.  Familial schwannomatosis: exclusion of the NF2 locus as the germline event.

Authors:  M MacCollin; C Willett; B Heinrich; L B Jacoby; J S Acierno; A Perry; D N Louis
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

View more
  11 in total

1.  Visual field loss in children with craniosynostosis.

Authors:  Alki Liasis; Bronwen Walters; Dorothy Thompson; Kate Smith; Richard Hayward; Ken K Nischal
Journal:  Childs Nerv Syst       Date:  2011-01-29       Impact factor: 1.475

2.  A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.

Authors:  Rosario Caltabiano; Gaetano Magro; Agata Polizzi; Andrea Domenico Praticò; Andrea Ortensi; Valerio D'Orazi; Andrea Panunzi; Pietro Milone; Luigi Maiolino; Francesco Nicita; Gabriele Lorenzo Capone; Roberta Sestini; Irene Paganini; Mariella Muglia; Sebastiano Cavallaro; Salvatore Lanzafame; Laura Papi; Martino Ruggieri
Journal:  Childs Nerv Syst       Date:  2017-04-01       Impact factor: 1.475

3.  Introduction to phacomatoses (neurocutaneous disorders) in childhood.

Authors:  Martino Ruggieri; Agata Polizzi; Gioacchino Paolo Marceca; Stefano Catanzaro; Andrea D Praticò; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-09-17       Impact factor: 1.475

4.  Neurofibromatosis Type 1 Presenting with Ophthalmic Features: A Case Series.

Authors:  Gunjan Jain; Vaibhav Kumar Jain; Indra Kumar Sharma; Reena Sharma; Neeraj Saraswat
Journal:  J Clin Diagn Res       Date:  2016-11-01

Review 5.  Cancer predisposition in pediatric neuro-oncology-practical approaches and ethical considerations.

Authors:  Steffen Hirsch; Nicola Dikow; Stefan M Pfister; Kristian W Pajtler
Journal:  Neurooncol Pract       Date:  2021-05-28

6.  Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms.

Authors:  Martino Ruggieri; Andrea D Praticò; Agostino Serra; Luigi Maiolino; Salvatore Cocuzza; Rosario Caltabiano; Agata Polizzi
Journal:  Childs Nerv Syst       Date:  2016-09-26       Impact factor: 1.475

Review 7.  An Update on the Ophthalmologic Features in the Phakomatoses.

Authors:  Solmaz Abdolrahimzadeh; Andrea Maria Plateroti; Santi Maria Recupero; Alessandro Lambiase
Journal:  J Ophthalmol       Date:  2016-07-17       Impact factor: 1.909

Review 8.  Systemic and ocular manifestations of a patient with mosaic ARID1A-associated Coffin-Siris syndrome and review of select mosaic conditions with ophthalmic manifestations.

Authors:  Virginia Miraldi Utz; Diana S Brightman; Monica A Sandoval; Robert B Hufnagel; Howard M Saal
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-09-05       Impact factor: 3.359

Review 9.  Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography.

Authors:  Barmak Abdolrahimzadeh; Domenica Carmen Piraino; Giorgio Albanese; Filippo Cruciani; Siavash Rahimi
Journal:  Clin Ophthalmol       Date:  2016-05-13

Review 10.  Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors.

Authors:  Heather B Radtke; Courtney D Sebold; Caroline Allison; Joy Larsen Haidle; Gretchen Schneider
Journal:  J Genet Couns       Date:  2007-07-17       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.